Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH

Antzeko izenburuak

• A nanoparticle therapeutic vaccine targeting HAAH stimulates cellular immunity
  nork: Lebowitz, Michael, et al.
  Argitaratua: (2015)
• Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH
  nork: Fuller, Steven, et al.
  Argitaratua: (2013)
• Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
  nork: Biswas, Biswajit, et al.
  Argitaratua: (2013)
• A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
  nork: Fuller, Steven, et al.
  Argitaratua: (2014)
• Enhanced immunogenicity of a nanoparticle therapeutic cancer vaccine targeting HAAH delivered intradermally using 3M's hollow microstructured transdermal system (hMTS)
  nork: Fuller, Steven, et al.
  Argitaratua: (2015)